clotrimazole and everolimus

clotrimazole has been researched along with everolimus in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Hosomi, K; Ikura, M; Kawase, A; Matsuda, S; Oita, A; Takada, M; Takenaka, H; Terakawa, N; Uno, T; Wada, K; Yokoyama, S	1

Reviews

1 review(s) available for clotrimazole and everolimus

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

1 other study(ies) available for clotrimazole and everolimus

Article	Year
Clotrimazole troches can alter everolimus pharmacokinetics in post-transplant patients: A case report. British journal of clinical pharmacology, 2019, Volume: 85, Issue:9 Topics: Administration, Mucosal; Adult; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis, Oral; Cardiomyopathy, Dilated; Clotrimazole; Drug Interactions; Drug Monitoring; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male	2019

Article

Year

Clotrimazole troches can alter everolimus pharmacokinetics in post-transplant patients: A case report.

British journal of clinical pharmacology, 2019, Volume: 85, Issue:9

Topics: Administration, Mucosal; Adult; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis, Oral; Cardiomyopathy, Dilated; Clotrimazole; Drug Interactions; Drug Monitoring; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male

2019